BNP/CALL/PFIZER INC/32/0.1/17.01.25 | Market Closed - Deutsche Boerse AG 15:50:29 2024-07-01 EDT | ||
| 0.078 EUR | +5.41% |
|
| Current month | +5.41% | ||
| 1 month | -29.09% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
PFIZER, INC.
Latest news about PFIZER, INC.
| Date | Price | Change |
|---|---|---|
| 24-07-01 | 0.078 | +5.41% |
| 24-06-28 | 0.074 | +19.35% |
| 24-06-27 | 0.062 | +1.64% |
| 24-06-26 | 0.061 | -15.28% |
| 24-06-25 | 0.072 | -8.86% |
Delayed Quote Deutsche Boerse AG
Last update July 01, 2024 at 03:50 pm
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | PFIZER, INC. |
| Issuer | 
BNP Paribas
|
| WKN | PN7FB6 |
| ISIN | DE000PN7FB68 |
| Date issued | 2023-08-17 |
| Strike | 32 $ |
| Maturity | 2025-01-17 (200 Days) |
| Parity | 10 : 1 |
| Emission price | 0.57 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.71 € |
|---|---|
| Lowest since issue | 0.041 € |
| Spread | 0.013 € |
| Spread % | 14.29% |
Company Profile
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows:
- primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.;
- specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.;
- oncology products (12.1%);
- other (1.3%).
At the end of 2022, the group had more than 35 manufacturing sites worldwide.
Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
Consensus: Pfizer, Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
28.22
USD
Average target price
31.92
USD
Spread / Average Target
+13.10%
- Stock Market
- Warrants
- Warrant
